Deformylase as a novel antibacterial target.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Drug Discovery Today

• Publication date

  2001-09-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1359-6446(01)01925-0PMID 11546610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resistance of Streptococcus pneumoniaeto Deformylase Inhibitors Is Due to Mutations indefB

  2001cited by this paper
• Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor

  2001cited by this paper
• Peptide Deformylase as an Antibacterial Drug Target: Target Validation and Resistance Development

  2001cited by this paper
• Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.

  2000cited by this paper
• Novel nonpeptidic inhibitors of peptide deformylase.

  2000cited by this paper
• Peptide Deformylase in Staphylococcus aureus: Resistance to Inhibition Is Mediated by Mutations in the Formyltransferase Gene

  2000cited by this paper
• Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.

  2000cited by this paper
• Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents?

  2000cited by this paper
• Identification of eukaryotic peptide deformylases reveals universality of N‐terminal protein processing mechanisms

  2000cited by this paper
• Protease inhibitors: current status and future prospects.

  2000cited by this paper
• Synthesis and antibacterial activity of peptide deformylase inhibitors.

  2000cited by this paper
• Inhibition of bacterial peptide deformylase by biaryl acid analogs.

  2000cited by this paper
• Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents

  2000cited by this paper
• Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133.

  2000cited by this paper
• Global transposon mutagenesis and a minimal Mycoplasma genome.

  1999cited by this paper
• Physiological Role of the N-terminal Processed P4501A1 Targeted to Mitochondria in Erythromycin Metabolism and Reversal of Erythromycin-mediated Inhibition of Mitochondrial Protein Synthesis*

  1999cited by this paper
• Peptide aldehyde inhibitors of bacterial peptide deformylases.

  1999cited by this paper
• Structural basis for the design of antibiotics targeting peptide deformylase.

  1999cited by this paper
• Inhibitors of protein synthesis.

  1999cited by this paper
• Design and synthesis of substrate analogue inhibitors of peptide deformylase.

  1999cited by this paper
• Formylation Is Not Essential for Initiation of Protein Synthesis in All Eubacteria*

  1999cited by this paper
• Substrate recognition and selectivity of peptide deformylase. Similarities and differences with metzincins and thermolysin.

  1999cited by this paper
• Oxygen-mediated Inactivation of Peptide Deformylase*

  1998cited by this paper
• Structure of Peptide Deformylase and Identification of the Substrate Binding Site*

  1998cited by this paper
• Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site.

  1998cited by this paper
• H-phosphonate derivatives as novel peptide deformylase inhibitors.

  1998cited by this paper
• Solution structure of nickel-peptide deformylase.

  1998cited by this paper
• Iron center, substrate recognition and mechanism of peptide deformylase

  1998cited by this paper
• PEPTIDE DEFORMYLASE : A NEW TYPE OF MONONUCLEAR IRON PROTEIN

  1997cited by this paper
• A survey of polypeptide deformylase function throughout the eubacterial lineage.

  1997cited by this paper
• Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.

  1997cited by this paper
• Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion.

  1997cited by this paper
• Crystal structure of the Escherichia coli peptide deformylase.

  1997cited by this paper
• A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase.

  1996cited by this paper
• Enzymatic properties of Escherichia coli peptide deformylase

  1995cited by this paper
• Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation.

  1994cited by this paper
• Characterization of the Thermus thermophilus locus encoding peptide deformylase and methionyl-tRNA(fMet) formyltransferase

  1994cited by this paper
• Evidence that peptide deformylase and methionyl-tRNA(fMet) formyltransferase are encoded within the same operon in Escherichia coli

  1993cited by this paper
• Methionine as translation start signal: a review of the enzymes of the pathway in Escherichia coli.

  1993cited by this paper
• Enzymes degrading bacterial chemotactic F‐met peptides in human ileal and colonic mucosa

  1990cited by this paper
• Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actions

  1982cited by this paper
• Initiation of protein synthesis in isolated mitochondria and chloroplasts.

  1980cited by this paper
• Keten dithioacetals. Part 11. Reaction of 3-cyano-4-methylthio-2(1H)-pyridones with hydrazine and guanidine: synthesis of novel substituted and fused pyrazolo[4,3-c]pyridone and pyrido[4,3-d]pyrimidine derivatives

  1978cited by this paper
• Studies concerning the antibiotic actinonin. Part VIII. Structure-activity relationships in the actinonin series.

  1975cited by this paper
• On the release of the formyl group from nascent protein.

  1968cited by this paper
• N-formylmethionyl-sRNA as the initiator of protein synthesis.

  1966cited by this paper
• Actinonin: an Antibiotic Substance produced by an Actinomycete

  1962cited by this paper

• In Silico Approach for Identifying Potent Natural Peptide Deformylase Inhibitors to Combat Antibacterial Resistance

  2025cites this paper
• Rational design of structurally rigidified ketone-peptide deformylase inhibitors with enhanced membrane permeability for combating gram-negative bacterial infections

  2025cites this paper
• Microwave-assisted N-formylation of active pharmaceutical ingredients (APIs) and intermediates, and screening of their N-formylated derivatives towards anti-bacterial potential

  2025cites this paper
• Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of E. coli Peptide Deformylase.

  2024cites this paper
• Penicillium molds impact the transcriptome and evolution of the cheese bacterium Staphylococcus equorum

  2023cites this paper
• Antibacterial, anti-biofilm, and anti-virulence potential of tea tree oil against leaf blight pathogen Xanthomonas oryzae pv. oryzae instigates disease suppression

  2022cites this paper
• Design Principles and Development of Prodrugs for Multiply Active Antibacterials

  2021cites this paper
• Novel structural hybrids of quinoline and thiazole moieties: Synthesis and evaluation of antibacterial and antifungal activities with molecular modeling studies.

  2021cites this paper
• Design, one-pot synthesis, molecular docking study, and antibacterial evaluation of novel 2H-chromene based imidazo[1,2-a]pyridine derivatives as potent peptide deformylase inhibitors

  2021cites this paper
• Synthesis and Anti-cancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.

  2020cites this paper
• Synthesis and Antibacterial Activity of New Chiral Aminoalcohol and Benzimidazole Hybrids

  2020cites this paper
• Total synthesis of (±)-fumimycin and analogues for biological evaluation as peptide deformylase inhibitors.

  2019cites this paper
• Peptide Deformylase (def) is essential in Mycobacterium smegmatis, but the essentiality is compensated by inactivation of methionine formylation

  2019cites this paper
• Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.

  2019cites this paper
• Prediction of different antibacterial activity in a new set of formyl hydroxyamino derivatives with potent action on peptide deformylase using structural information

  2018cites this paper
• Design, Synthesis, and Antibacterial Activities of Novel Heterocyclic Arylsulphonamide Derivatives

  2017cites this paper
• Caractérisation structurale et fonctionnelle de la peptide déformylase du phage Vp16T

  2016cites this paper
• Biosynthesis of steroidal antibiotic fusidanes: Functional analysis of oxidosqualene

  2016cites this paper
• Bacterial Peptide deformylase inhibition of cyano substituted biaryl analogs: Synthesis, in vitro biological evaluation, molecular docking study and in silico ADME prediction.

  2016cites this paper
• Replaying the evolution of FMET : experimental evidence that translation initiation in bacteria was invaded by a selfish genetic element.

  2016cites this paper
• Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria.

  2016cites this paper
• A unique peptide deformylase platform to rationally design and challenge novel active compounds

  2016cites this paper
• Bacterial Peptide Deformylase Inhibition of Tetrazole‐Substituted Biaryl Acid Analogs: Synthesis, Biological Evaluations, and Molecular Docking Study

  2016cites this paper
• Molecular modeling of Plasmodium falciparum peptide deformylase and structure-based pharmacophore screening for inhibitors

  2016cites this paper
• Molecular Docking Studies of 1,3,4-Thiadiazoles as Novel Peptide Deformylase Inhibitors as Potential Antibacterial Agents

  2015cites this paper
• Structures of actinonin-bound peptide deformylases from Enterococcus faecalis and Streptococcus pyogenes

  2014cites this paper
• Bacterial peptide deformylase inhibitor PMT analogs inhibit cancer cell growth by interacting with human peptide deformylase

  2014cites this paper
• Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.

  2014cites this paper
• Enantioselective Intramolecular Aza-Spiroannulation onto Benzofurans Using Chiral Rhodium Catalysis.

  2014cites this paper
• A Concise Synthesis of (±)-Methoxyfumimycin Ethyl Ester

  2014cites this paper
• DOCKING BASED PHARMACOPHORE MODEL FOR MYCOBACTERIUM TUBERCULOSIS PEPTIDE DEFORMYLASE INHIBITORS AND ITS APPLICATION IN DRUG DESIGNING

  2014cites this paper
• Strategies to Discover Novel Antimicrobials to Cope with Emerging Medical Needs

  2014cites this paper
• Synthesis of the intermediate for fumimycin: a natural peptide deformylase inhibitor

  2013cites this paper
• Caffeic acid phenethyl ester (CAPE), an active component of propolis, inhibits Helicobacter pylori peptide deformylase activity.

  2013cites this paper
• Emerging drugs on methicillin-resistant Staphylococcus aureus

  2013cites this paper
• Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.

  2012cites this paper
• Antimicrobial activities of endophytic fungi isolated from Ophiopogon japonicus (Liliaceae)

  2012cites this paper
• Antimicrobial activities of endophytic fungi isolation from Ophiopogon japonicus

  2012cites this paper
• Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors

  2012cites this paper
• 3D-QSAR and molecular docking studies of hydroxamic acids as peptide deformylase inhibitors

  2012cites this paper
• A Phage-Guided Route to Discovery of Bioactive Rare Actinomycetes

  2012cites this paper
• In vitro antimicrobial and molecular docking of dichloro substituted benzoxazole derivatives

  2012cites this paper
• Small colony variants in Staphylococcus aureus and other species: antibiotic selection, antimicrobial susceptibility, and biofilm formation

  2011influential citation
• Computer aided discovery of benzimidazole derivatives on peptide deformylase as antimicrobial agent using hex

  2011cites this paper
• Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.

  2011cites this paper
• Trapping Conformational States Along Ligand-Binding Dynamics of Peptide Deformylase: The Impact of Induced Fit on Enzyme Catalysis

  2011cites this paper
• Structural and Pharmacological Effects of Ring-Closing Metathesis in Peptides

  2010cites this paper
• Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.

  2010cites this paper
• Isolation and Identification of FR198248, a Hydroxylated 1,3-Dihydroisobenzofuran, from Aspergillus flavipes as an Inhibitor of Peptide Deformylase

  2010cites this paper
• Asymmetric total synthesis of (+)-fumimycin via 1,2-addition to ketimines.

  2010cites this paper
• Synthesis and preliminary antibacterial evaluation of 2-butyl succinate-based hydroxamate derivatives containing isoxazole rings

  2010cites this paper
• The total synthesis of (±)-fumimycin.

  2010cites this paper
• Synthesis of methoxyfumimycin with 1,2-addition to ketimines.

  2010cites this paper
• Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.

  2010cites this paper
• In Silico Study of the Selective Inhibition of Bacterial Peptide Deformylases by Several Drugs

  2010cites this paper
• Surmounting antimicrobial resistance in the Millennium Superbug: Staphylococcus aureus

  2010cites this paper
• Mechanisms of metal-dependent hydrolases in metabolism

  2010cites this paper
• Hydroxamic Acids: Biological Properties and Potential Uses as Therapeutic Agents

  2010cites this paper
• Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.

  2010cites this paper
• Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery

  2009cites this paper
• Towards an asymmetric synthesis of the bacterial peptide deformylase (PDF) inhibitor fumimycin.

  2009cites this paper
• Proteomic analysis of Staphylococcus aureus biofilms grown in vitro on mechanical heart valve leaflets.

  2009cites this paper
• In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv.

  2009cites this paper
• Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery

  2009cites this paper
• Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.

  2009cites this paper
• COMPUTATIONAL STUDY OF THE DYNAMICS OF PEPTIDE DEFORMYLASE COMPLEX FROM LEPTOSPIRA INTERROGANS: EXPLORING THE CONFORMATIONAL CHANGES OF THE SUBSTRATE POCKET

  2008cites this paper
• The decline of antibiotic era--new approaches for antibacterial drug discovery.

  2008cites this paper
• High-throughput screening of peptide deformylase inhibitors.

  2008cites this paper
• Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.

  2008cites this paper
• Initiation of protein synthesis: a target for antimicrobials

  2008influential citation
• Comparative QSAR studies on peptide deformylase inhibitors

  2007cites this paper
• Catalytic mechanism and metal specificity of bacterial peptide deformylase: a density functional theory QM/MM study.

  2007cites this paper
• Macrolactins O-R, glycosylated 24-membered lactones from Bacillus sp. AH159-1.

  2007cites this paper
• Theoretical study of the catalytic mechanism and metal-ion dependence of peptide deformylase.

  2007cites this paper
• Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis.

  2006cites this paper
• Phylogenomic and Biochemical Characterization of Three Legionella pneumophila Polypeptide Deformylases

  2006cites this paper
• SIMULATION STUDY OF THE EFFECTS OF LIGAND ON THE ACTIVE ZONE OF THE PEPTIDE DEFORMYLASE

  2006cites this paper
• Chapter 15 Structure-Based Design of New Antibacterial Agents

  2006cites this paper
• Proteomic Study of Peptide Deformylase Inhibition in Streptococcus pneumoniae and Staphylococcus aureus

  2006cites this paper
• Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets.

  2006cites this paper
• The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.

  2006cites this paper
• Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development

  2006cites this paper
• Geometric preferences in iron(II) and zinc(II) model complexes of peptide deformylase.

  2006cites this paper
• Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents

  2006cites this paper
• New targets and screening approaches in antimicrobial drug discovery.

  2005cites this paper
• Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase (PDF) from Bacillus cereus in ligand-free and actinonin-bound forms.

  2005cites this paper
• Structure analysis of peptide deformylase from Bacillus cereus

  2005cites this paper
• Peptide deformylase inhibitors: a survey of the patent literature

  2005cites this paper
• Comparative Antimicrobial Characterization of LBM415 (NVP PDF-713), a New Peptide Deformylase Inhibitor of Clinical Importance

  2005cites this paper
• The Crystal Structure of Mitochondrial (Type 1A) Peptide Deformylase Provides Clear Guidelines for the Design of Inhibitors Specific for the Bacterial Forms*

  2005cites this paper
• Therapeutic potential of peptide deformylase inhibitors

  2005cites this paper
• Peptidyl Deformylase Inhibitors

  2005cites this paper
• 15th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark, 2-5 April 2005. Abstracts.

  2005cites this paper
• Inhibition of peptide deformylase in Nicotiana tabacum leads to decreased D1 protein accumulation, ultimately resulting in a reduction of photosystem II complexes.

  2004cites this paper
• Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.

  2004cites this paper
• In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.

  2004cites this paper
• Identification of novel potent bicyclic peptide deformylase inhibitors.

  2004cites this paper
• Peptide deformylase inhibitors with activity against respiratory tract pathogens.

  2004cites this paper
• Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.

  2004cites this paper
• Peptide Deformylase Inhibitors as Antibacterial Agents: Identification of VRC3375, a Proline-3-Alkylsuccinyl Hydroxamate Derivative, by Using an Integrated Combinatorial and Medicinal Chemistry Approach

  2004cites this paper